Marko Anderluh - Concepedia

Author

Marko Anderluh

Also Known As

Anderluh, M., Anderluh, Marko, M. Anderluh, Marko Anderluh, Petra Anderluh, Petra Stefanic Anderluh, Petra Štefanič Anderluh

146

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

University of Ljubljana National Institute of Chemistry Blood Transfusion Centre of Slovenia Centre National de la Recherche Scientifique Jožef Stefan Institute

About

Marko Anderluh is an author at University of Ljubljana specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	27	825
2	Natural Sciences	15	18	558
3	Biochemistry	14	19	503
4	Engineering	4	4	67
5	Public Health	1	1	26

Marko Anderluh

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-<i>d</i>]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site Tihomir Tomašič, Sotirios Katsamakas, Žiga Hodnik, Journal of Medicinal Chemistry Drug TargetAntibacterial ActivityBacterial Dna GyraseAntimicrobial ChemotherapyChemical Biology	2015	108
TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions Nitin H. Shirole, Debjani Pal, Edward R. Kastenhuber, eLife	2016	78
5‐Benzylidenethiazolidin‐4‐ones as Multitarget Inhibitors of Bacterial Mur Ligases Tihomir Tomašič, Nace Zidar, Andreja Kovač, ChemMedChem Inhibitory ActivityAntimicrobial Drug DiscoveryAntibioticsMedicineDifferent Strains	2009	74
Synthesis of Novel DC‐SIGN Ligands with an α‐Fucosylamide Anchor Gabriele Timpano, Georges Tabarani, Marko Anderluh, ChemBioChem Medicinal ChemistryNatural SciencesCoordination ComplexGlycobiologyImmunology	2008	60
Toward a Novel Class of Antithrombotic Compounds with Dual Function. Discovery of 1,4-Benzoxazin-3(4<i>H</i>)-one Derivatives Possessing Thrombin Inhibitory and Fibrinogen Receptor Antagonistic Activities Marko Anderluh, Janez Ilaš, Janez Mravljak, Journal of Medicinal Chemistry PharmacotherapyChemical BiologyPharmaceutical ChemistryChemical DerivativeMolecular Pharmacology	2005	51
Potent DNA gyrase inhibitors bind asymmetrically to their target using symmetrical bifurcated halogen bonds Anja Kolarič, Thomas Germe, Martina Hrast, Nature Communications	2021	51
Three-component one-pot synthetic route to 2-amino-5-alkylidene-thiazol-4-ones Marko Anderluh, Marko Jukič, Rok Petrič Tetrahedron Organic ChemistryDiversity Oriented SynthesisChemistry	2008	49
Xanthine oxidase inhibitory properties and anti-inflammatory activity of 2-amino-5-alkylidene-thiazol-4-ones Žaklina Šmelcerović, Andrej Veljković, Gordana Kocić, Chemico-Biological Interactions Anti-inflammatoryAntiparasitic AgentMedicinePharmacologyAnti-inflammatory Activity	2015	43
Design and synthesis of novel platelet fibrinogen receptor antagonists with 2H-1,4-benzoxazine-3(4H)-one scaffold. A systematic study Marko Anderluh, Jožko Cesar, Petra Peharec Štefanić, European Journal of Medicinal Chemistry Thrombosis-One ScaffoldBlood PlateletMedicinePharmacotherapy	2004	41
Monovalent and bivalent N-fucosyl amides as high affinity ligands for Pseudomonas aeruginosa PA-IIL lectin Manuel Andreini, Marko Anderluh, Aymeric Audfray, Carbohydrate Research BiochemistryAntibacterial AgentHigh Affinity LigandsMicrobiologyBivalent N-fucosyl Amides	2010	36

Page 1